Clinical Trial

Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest

Study acronym: VascuLens RCT
Enrolling by Invitation Phase 1
View on ClinicalTrials.gov →
Summary
This study incorporates the use of the VascuLens system, which relies on a mixed reality headset and software system, during the pre-operative stage of DIEP flap surgery. VascuLens utilizes augmented reality (AR) technology to project vasculature images obtained from computed tomography angiography (CTA) onto the patient's body. These projections are then traced onto the patient, and the accuracy of the key vascular anatomical landmarks in the projected images is compared to the accuracy of the conventional surgical markings of the same anatomical landmarks against the actual location of the dissected blood vessels. Higher accuracy may lead to improved patient care, reduced operative time and reduced risk of complications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-14.
Trial Details
NCT Number NCT07080463
Lead Sponsor University of British Columbia
Conditions Breast Cancer
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-10